Investigation of intravenous administration of non-hematopoietic umbilical cord blood cells as a therapy for stroke
2013-05
Loading...
View/Download File
Persistent link to this item
Statistics
View StatisticsJournal Title
Journal ISSN
Volume Title
Title
Investigation of intravenous administration of non-hematopoietic umbilical cord blood cells as a therapy for stroke
Authors
Published Date
2013-05
Publisher
Type
Thesis or Dissertation
Abstract
Stroke is one of the leading causes of death in the United States. Limitations of currently available stroke treatment include a 3 hour time window for recombinant tissue plasminogen activator. Stem cells have become promising for the treatment of a variety of neurodegenerative diseases, including stroke. Therapies in this category include stimulation of endogenous neurogenesis, as well as the delivery of exogenous stem cells.This thesis focuses on the investigation of the intravenous delivery of a CD34 negative subset of umbilical cord blood stem cells as a therapy for stroke. Methods employed for this investigation include next generation sequencing technologies for gene expression profiling, 19-fluorine tracking of stem cells with MRI, and fluorescence biodistribution tracking.
Keywords
Description
University of Minnesota M.S. thesis. May 2013. Major: Stem cell biology. Advisor: Andrew Grande. 1 computer file (PDF); iv, 54 pages.
Related to
Replaces
License
Series/Report Number
Funding information
Isbn identifier
Doi identifier
Previously Published Citation
Suggested citation
Juliano, Mario. (2013). Investigation of intravenous administration of non-hematopoietic umbilical cord blood cells as a therapy for stroke. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/156768.
Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.